Moderate-to-severe benign prostatic hyperplasia (BPH)

Clinical trials for Moderate-to-severe benign prostatic hyperplasia (BPH) explained in plain language.

Never miss a new study

Get alerted when new Moderate-to-severe benign prostatic hyperplasia (BPH) trials appear

Sign up with your email to follow new studies for Moderate-to-severe benign prostatic hyperplasia (BPH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Completed 1

New prostate drug candidate put to the test in healthy volunteers

Disease control Not yet recruiting

This early-stage trial will compare a new drug called AJU-G721 to an existing reference drug, G721R, in 36 healthy adult men. The goal is to see if the two drugs produce similar levels in the blood and have comparable safety. Both drugs contain tamsulosin, which is used to treat …

Matched conditions: MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIA (BPH)

Phase 1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:06 UTC

Moderate-to-severe benign prostatic hyperplasia (BPH)

Get alerted when new Moderate-to-severe benign prostatic hyperplasia (BPH) trials appear

New prostate drug candidate put to the test in healthy volunteers